Atlas Trials

Medicago

18 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Medicago

RecordFirmDate
Phase 3 Study to Evaluate the Lot Consistency of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine (NCT05040789)Medicago2021-11-22
Safety Immunogenicity Study of MT-2766 in Japanese Adults（COVID-19） (NCT05065619)Medicago2021-10-02
Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults (NCT04636697)Medicago2020-11-19
Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older (NCT04622592)Medicago2020-11-02
Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years. (NCT04450004)Medicago2020-07-10
Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly (NCT03739112)Medicago2018-09-18

Track Medicago automatically

Every clearance here is in the API, with alerts when new ones post.